Effect of Hyperuricaemia on Chronic Renal Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT03425708
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Registry
-
NCT03425708
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03425708. Randomized; single masking; primary purpose treatment. Start 2017-01-01 (actual); primary completion 2018-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Hyperuricaemia on Chronic Renal Disease
- Condition
- Hyperuricemia
- Condition
- Chronic Renal Disease
- Intervention (Drug)
- 20mg Febuxostat
- Intervention (Drug)
- 40mg Febuxostat
- Lead sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Collaborator
- The First People's Hospital of Xuzhou
Record details
- Record id
cardio:ct-nct03425708- Content hash
fc73c4bbd3e12f7b4110a312a95922f76f59007ed0a37bd9b8d80d6c6b4fff44